Editas Medicine, Inc.
EDIT
$2.82
$0.010.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 232.31% | -39.22% | -19.16% | 12,265.57% | 597.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 232.31% | -39.22% | -19.16% | 12,265.57% | 597.47% |
| Cost of Revenue | 24.71% | -33.82% | -43.63% | -58.49% | -70.15% |
| Gross Profit | 34.22% | 32.67% | 85.21% | 74.29% | 76.53% |
| SG&A Expenses | -9.77% | -23.48% | -30.58% | -31.91% | -29.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.45% | -30.36% | -40.34% | -51.18% | -59.90% |
| Operating Income | 21.87% | 29.19% | 59.21% | 62.62% | 64.59% |
| Income Before Tax | 65.76% | 67.17% | 87.62% | 59.58% | 21.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.76% | 67.17% | 87.62% | 59.58% | 21.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.76% | 67.17% | 87.62% | 59.58% | 21.26% |
| EBIT | 21.87% | 29.19% | 59.21% | 62.62% | 64.59% |
| EBITDA | 17.57% | 26.57% | 57.64% | 62.81% | 66.48% |
| EPS Basic | 75.77% | 72.14% | 89.48% | 62.99% | 23.22% |
| Normalized Basic EPS | 49.00% | 40.82% | 75.17% | 63.00% | 60.85% |
| EPS Diluted | 75.77% | 72.14% | 89.48% | 62.99% | 23.22% |
| Normalized Diluted EPS | 49.00% | 40.82% | 75.17% | 63.00% | 60.85% |
| Average Basic Shares Outstanding | 41.32% | 17.85% | 17.72% | 9.22% | 2.55% |
| Average Diluted Shares Outstanding | 41.32% | 17.85% | 17.72% | 9.22% | 2.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |